tiprankstipranks
Passage Bio reports Q4 EPS (30c), consensus (40c)
PremiumThe FlyPassage Bio reports Q4 EPS (30c), consensus (40c)
2M ago
Passage Bio to Participate in Upcoming Investor Conferences
PremiumPress Releases
Passage Bio to Participate in Upcoming Investor Conferences
2M ago
Passage Bio to Present at Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
PremiumPress Releases
Passage Bio to Present at Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
3M ago
Passage Bio announces initial data from Phase 1/2 trial of PBFT02
PremiumThe FlyPassage Bio announces initial data from Phase 1/2 trial of PBFT02
4M ago
Passage Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
PremiumPress Releases
Passage Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
5M ago
Passage Bio Reports Third Quarter 2023 Financial Results and Provides Recent Business Highlights
PremiumPress Releases
Passage Bio Reports Third Quarter 2023 Financial Results and Provides Recent Business Highlights
5M ago
Passage Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PremiumPress ReleasesPassage Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
6M ago
Passage Bio to Present at Chardan’s 7th Annual Genetic Medicines Conference
PremiumPress Releases
Passage Bio to Present at Chardan’s 7th Annual Genetic Medicines Conference
7M ago
Passage Bio price target lowered to $9 from $11 at Chardan
PremiumThe Fly
Passage Bio price target lowered to $9 from $11 at Chardan
9M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100